ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE00BYXG2H39
Stock Name / FundiShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF TickerBTEC(USD) LSE
ETF TickerBTEK(GBP) LSE
ETF Ticker2B70(EUR) F
ETF Ticker2B70.DE(EUR) CXE
ETF TickerBTEC.LS(USD) CXE
ETF TickerBTEK.LS(GBP) CXE
ETF TickerBTEC.L(GBP) LSE
ETF TickerBTEK.L(GBP) LSE

Holdings detail for ORKA

Stock NameOruka Therapeutics, Inc.
TickerORKA(USD) NASDAQ
TYPECommon Stock
CountryUSA

Show aggregate ORKA holdings

News associated with ORKA

BTIG Research Forecasts Strong Price Appreciation for Oruka Therapeutics (NASDAQ:ORKA) Stock
Oruka Therapeutics (NASDAQ:ORKA – Get Free Report) had its price target lifted by investment analysts at BTIG Research from $44.00 to $56.00 in a report released on Wednesday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. BTIG Research’s price target suggests a potential upside of 237.76% from the stock’s previous close. Other […] - 2025-09-19 02:36:47
Oruka Therapeutics Reports Positive Interim Data From Phase 1 Study Of ORKA-001
(RTTNews) - Oruka Therapeutics, Inc. (ORKA) Tuesday announced positive interim data from its Phase 1 study evaluating the safety and pharmacokinetics of ORKA-001 in healthy volunteers. - 2025-09-17 02:47:22
HC Wainwright Reaffirms Buy Rating for Oruka Therapeutics (NASDAQ:ORKA)
Oruka Therapeutics (NASDAQ:ORKA – Get Free Report)‘s stock had its “buy” rating restated by equities researchers at HC Wainwright in a research report issued on Monday,Benzinga reports. They presently have a $45.00 price target on the stock. HC Wainwright’s target price would indicate a potential upside of 209.07% from the company’s current price. ORKA has […] - 2025-08-20 02:18:52
Oruka Therapeutics, Inc. (NASDAQ:ORKA) Receives $40.38 Average Target Price from Analysts
Oruka Therapeutics, Inc. (NASDAQ:ORKA – Get Free Report) has received a consensus rating of “Buy” from the ten ratings firms that are currently covering the company, MarketBeat Ratings reports. Eight analysts have rated the stock with a buy rating and two have issued a strong buy rating on the company. The average 12 month price […] - 2025-08-12 02:30:47
Analysts Set Oruka Therapeutics, Inc. (NASDAQ:ORKA) Price Target at $40.38
Shares of Oruka Therapeutics, Inc. (NASDAQ:ORKA – Get Free Report) have earned an average rating of “Buy” from the ten analysts that are presently covering the firm, Marketbeat.com reports. Eight equities research analysts have rated the stock with a buy recommendation and two have assigned a strong buy recommendation to the company. The average 12 […] - 2025-06-23 02:14:10
Oruka Therapeutics, Inc. (NASDAQ:ORKA) Shares Acquired by Wellington Management Group LLP
Wellington Management Group LLP increased its position in shares of Oruka Therapeutics, Inc. (NASDAQ:ORKA – Free Report) by 15.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 95,089 shares of the company’s stock after purchasing an additional 12,952 shares during the quarter. […] - 2025-06-06 05:39:01
Oruka Therapeutics, Inc. (NASDAQ:ORKA) Receives Average Recommendation of “Buy” from Brokerages
Shares of Oruka Therapeutics, Inc. (NASDAQ:ORKA – Get Free Report) have been given an average rating of “Buy” by the ten brokerages that are covering the stock, Marketbeat Ratings reports. Eight research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. The average 12 […] - 2025-05-26 02:20:51
Comparing Oruka Therapeutics (NASDAQ:ORKA) and Achieve Life Sciences (NASDAQ:ACHV)
Achieve Life Sciences (NASDAQ:ACHV – Get Free Report) and Oruka Therapeutics (NASDAQ:ORKA – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, dividends, earnings, profitability, analyst recommendations, valuation and risk. Profitability This table compares Achieve Life […] - 2025-03-24 03:37:03
Head-To-Head Contrast: Oruka Therapeutics (NASDAQ:ORKA) and Celldex Therapeutics (NASDAQ:CLDX)
Oruka Therapeutics (NASDAQ:ORKA – Get Free Report) and Celldex Therapeutics (NASDAQ:CLDX – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, earnings, risk, analyst recommendations, institutional ownership, dividends and valuation. Institutional and Insider Ownership 56.4% of Oruka […] - 2025-03-13 04:26:59
Oruka Therapeutics, Inc. (NASDAQ:ORKA) Receives $39.86 Consensus Target Price from Brokerages
Oruka Therapeutics, Inc. (NASDAQ:ORKA – Get Free Report) has earned a consensus recommendation of “Buy” from the nine research firms that are currently covering the company, Marketbeat.com reports. Seven equities research analysts have rated the stock with a buy rating and two have issued a strong buy rating on the company. The average twelve-month price […] - 2025-02-18 04:12:49

iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) ORKA holdings

DateNumber of ORKA Shares HeldBase Market Value of ORKA SharesLocal Market Value of ORKA SharesChange in ORKA Shares HeldChange in ORKA Base ValueCurrent Price per ORKA Share HeldPrevious Price per ORKA Share Held
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of ORKA by Blackrock for IE00BYXG2H39

Show aggregate share trades of ORKA

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-10-06BUY18920.33021.200 21.113USD 3,990 12.51
2025-10-03BUY44119.79019.860 19.853USD 8,755 12.47
2025-10-02BUY6319.18019.720 19.666USD 1,239 12.44
2025-09-30BUY12619.23020.000 19.923USD 2,510 12.36
2025-09-26BUY12615.20015.650 15.605USD 1,966 12.31
2025-09-25BUY12615.05015.520 15.473USD 1,950 12.30
2025-09-18BUY6416.58016.840 16.814USD 1,076 12.25
2025-09-17BUY19216.21018.500 18.271USD 3,508 12.23
2025-09-11SELL-6316.15016.160 16.159USD -1,018 12.16 Loss of -252 on sale
2025-09-10BUY12615.77016.210 16.166USD 2,037 12.14
2025-09-05SELL-6316.35016.880 16.827USD -1,060 12.07 Loss of -300 on sale
2025-08-29SELL-18914.80015.340 15.286USD -2,889 11.99 Loss of -622 on sale
2025-08-27BUY12615.18015.630 15.585USD 1,964 11.95
2025-08-26SELL-6314.81015.000 14.981USD -944 11.94 Loss of -192 on sale
2025-08-25BUY6314.51015.370 15.284USD 963 11.92
2025-08-20SELL-25214.40014.970 14.913USD -3,758 11.89 Loss of -763 on sale
2025-08-18BUY12615.25015.760 15.709USD 1,979 11.85
2025-08-08SELL-12613.09013.900 13.819USD -1,741 11.77 Loss of -258 on sale
2025-08-05BUY6215.50015.520 15.518USD 962 11.72
2025-08-01SELL-18613.60013.920 13.888USD -2,583 11.69 Loss of -409 on sale
2025-07-30BUY24813.79014.320 14.267USD 3,538 11.66
2025-07-17SELL-12415.36015.580 15.558USD -1,929 11.49 Loss of -505 on sale
2025-07-11SELL-50414.23014.370 14.356USD -7,235 11.39 Loss of -1,493 on sale
2025-07-07BUY18913.29013.670 13.632USD 2,576 11.32
2025-07-02BUY3,46512.61012.790 12.772USD 44,255 11.29
2025-06-25BUY12611.63011.830 11.810USD 1,488 11.29
2025-06-11BUY12812.60013.560 13.464USD 1,723 11.21
2025-06-10BUY12813.19013.300 13.289USD 1,701 11.20
2025-06-04SELL-6411.68012.310 12.247USD -784 11.16 Loss of -70 on sale
2025-04-23BUY6410.58011.130 11.075USD 709 11.43
2025-04-10SELL-5207.3707.660 7.631USD -3,968 11.80 Profit of 2,168 on sale
2025-04-08SELL-646.7807.900 7.788USD -498 11.95 Profit of 266 on sale
2025-04-07SELL-647.6207.870 7.845USD -502 12.02 Profit of 267 on sale
2025-04-04SELL-3257.8308.700 8.613USD -2,799 12.09 Profit of 1,129 on sale
2025-04-01BUY2609.56010.290 10.217USD 2,656 12.17
2025-03-31SELL-19210.26012.450 12.231USD -2,348 12.21 Loss of -5 on sale
2025-03-21BUY2,17612.10012.260 12.244USD 26,643 12.22
2025-03-14SELL-91211.09011.360 11.333USD -10,336 12.29 Profit of 872 on sale
2025-03-07SELL-11410.46010.700 10.676USD -1,217 12.44 Profit of 201 on sale
2025-03-04SELL-5710.14010.440 10.410USD -593 12.60 Profit of 125 on sale
2025-02-25BUY11410.64010.880 10.856USD 1,238 12.95
2025-02-19SELL-5710.76011.430 11.363USD -648 13.21 Profit of 105 on sale
2025-02-13BUY17111.43011.870 11.826USD 2,022 13.51
2025-02-12BUY5711.87012.110 12.086USD 689 13.57
2025-02-11BUY22810.98011.300 11.268USD 2,569 13.67
2025-01-17BUY22812.25013.000 12.925USD 2,947 16.02
2025-01-16BUY22412.60014.850 14.625USD 3,276 16.51
2025-01-10SELL-11215.72018.720 18.420USD -2,063 19.33 Profit of 102 on sale
2025-01-08SELL-22419.01019.290 19.262USD -4,315 19.97 Profit of 159 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of ORKA

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19156,3980183,16285.4%
2025-09-18294,7532403,15373.1%
2025-09-17524,52912,0071,032,42250.8%
2025-09-1659,897066,09290.6%
2025-09-1523,038035,64764.6%
2025-09-1221,308024,07888.5%
2025-09-1118,685022,12984.4%
2025-09-1021,279022,76893.5%
2025-09-0919,523021,97788.8%
2025-09-0831,664037,86783.6%
2025-09-0535,252076,63946.0%
2025-09-0420,700025,37581.6%
2025-09-0318,521023,65678.3%
2025-09-0257,023096,80658.9%
2025-08-2921,089026,91278.4%
2025-08-2811,833037,10331.9%
2025-08-2735,359064,87954.5%
2025-08-2611,306027,31941.4%
2025-08-2525,262045,19455.9%
2025-08-2245,520050,72689.7%
2025-08-2154,950095,42257.6%
2025-08-2035,454050,91069.6%
2025-08-1956,437072,66577.7%
2025-08-1835,207048,09873.2%
2025-08-1525,056054,33146.1%
2025-08-1442,702055,88076.4%
2025-08-1365,98797170,13338.8%
2025-08-1275,366077,97796.7%
2025-08-1137,622040,88692.0%
2025-08-0821,558025,12385.8%
2025-08-0738,7316043,11989.8%
2025-08-0644,65661568,95664.8%
2025-08-0534,903076,86345.4%
2025-08-0423,3541925,11193.0%
2025-08-0130,209038,90177.7%
2025-07-3124,887027,69989.8%
2025-07-3048,251850,88394.8%
2025-07-2933,3852337,38889.3%
2025-07-2821,744023,95190.8%
2025-07-2518,6809621,27087.8%
2025-07-2421,049824,83484.8%
2025-07-2328,897030,45694.9%
2025-07-2226,6488929,79289.4%
2025-07-2151,78790068,36275.8%
2025-07-1873,9942787,54884.5%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy